4.2 Article

Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis

Journal

PEDIATRIC RHEUMATOLOGY
Volume 13, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/s12969-015-0018-8

Keywords

Juvenile idiopathic arthritis; Uveitis; Risk factors; Quality of life

Funding

  1. National Eye Institute [K23EY021760]
  2. National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR060893]
  3. Marcus Foundation Inc.
  4. Arthritis Foundation

Ask authors/readers for more resources

Background: Juvenile idiopathic arthritis-associated uveitis (JIA-U) can lead to poor visual outcomes and impact a child's quality of life (QOL) and function. Our aim is to identify risk markers of JIA-U and examine differences in the QOL of children with JIA and JIA-U. Methods: Rheumatology and ophthalmology record reviews and questionnaires were completed every 4-6 months on 287 children with JIA. We collected arthritis, uveitis, and QOL data. We examined data through last study visit. Results: There were 52/287 (18 %) children with JIA-U who were younger at arthritis diagnosis, had oligoarticular persistent JIA, and ANA positive. Confirmed uveitis predictors were age at JIA diagnosis (OR = 0.86) and oligoarticular subtype (OR = 5.92). They had worse vision specific QOL and function, but similar general QOL. Blindness occurred in 17.5 % of children but was more common in African American children compared to non-Hispanic Caucasian children ((5/7 (71 %) vs. 2/29 (7 %), p < 0.001) despite a similar uveitis prevalence (22 % vs. 16 %). Both races had similar complications, although band keratopathy was more frequent in African Americans (75 % vs. 15.6 %, p = 0.003). Conclusions: We confirm young age at JIA diagnosis and the oligoarticular JIA subtype as predictors of uveitis development. Although we were unable to identify predictors of ocular complications or blindness, AA children appeared to have a more severe disease course manifested by increased ocular complications, vision loss and blindness. Potential causes that warrant additional study include underlying disease severity, access to medical care and referral bias. Further investigation of the risk factors for vision-compromising uveitis and its' long-term effects should be conducted in a large racially diverse population.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

S100 Proteins, Cytokines, and Chemokines as Tear Biomarkers in Children with Juvenile Idiopathic Arthritis-associated Uveitis

Sheila T. Angeles-Han, Virginia Miraldi Utz, Sherry Thornton, Grant Schulert, Jackeline Rodriguez-Smith, Adam Kauffman, Alyssa Sproles, Najima Mwase, Theresa Hennard, Alexei Grom, Mekibib Altaye, Gary N. Holland

Summary: In this study, inflammatory biomarkers in tears were successfully detected in children with JIA-U, with IL-8, sICAM-1, and S100A12 identified as potential biomarkers for uveitis activity.

OCULAR IMMUNOLOGY AND INFLAMMATION (2021)

Article Rheumatology

Assessing the Validity and Reliability of the Effects of Youngsters' Eyesight on Quality of Life Questionnaire Among Children With Uveitis

Amy Cassedy, Mekibib Altaye, Jennifer Andringa, Ashley M. Cooper, Carolyn Drews-Botsch, George Engelhard, Theresa Hennard, Gary N. Holland, Kirsten Jenkins, Scott R. Lambert, Jessi Lipscomb, Courtney McCracken, Deborah K. McCurdy, Joseph McDonald, Najima Mwase, Sampath Prahalad, Erin Stahl, Virginia Miraldi Utz, A. Adrienne Walker, Steven Yeh, Sheila T. Angeles-Han

Summary: The objective of this study was to revise and assess the validity of the EYE-Q questionnaire, which measures vision-related functioning and quality of life in children with uveitis. The study found that the EYE-Q is a valid tool for measuring these factors in pediatric uveitis patients.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Comprehensive Assessment of Quality of Life, Functioning, and Mental Health in Children With Juvenile Idiopathic Arthritis and Noninfectious Uveitis

Joseph McDonald, Amy Cassedy, Mekibib Altaye, Jennifer Andringa, Ashley M. Cooper, Carolyn Drews-Botsch, George Engelhard, Theresa Hennard, Gary N. Holland, Kirsten Jenkins, Scott R. Lambert, Jessi Lipscomb, Courtney McCracken, Deborah K. McCurdy, Najima Mwase, Sampath Prahalad, Jessica Shantha, Erin Stahl, Virginia Miraldi Utz, A. Adrienne Walker, Steven Yeh, Sheila T. Angeles-Han

Summary: Pediatric uveitis can have negative effects on quality of life, functioning, and mental health in children. The impact varies depending on the type of uveitis. Including vision-specific measures can provide a better understanding of the effects of uveitis.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Uveitis in Children and Adolescents

Margaret H. Chang, Jessica G. Shantha, Jacob J. Fondriest, Mindy S. Lo, Sheila T. Angeles-Han

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2021)

Article Rheumatology

Adverse Perinatal Outcomes Before and After Diagnosis of Systemic Lupus Erythematosus Among African American Women

Meghan Angley, Carolyn Drews-Botsch, Tene T. Lewis, Martina Badell, S. Sam Lim, Penelope P. Howards

Summary: This study found that among African American women, there is an increased risk of adverse perinatal outcomes even before a clinical diagnosis of SLE.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

Karen B. Onel, Daniel B. Horton, Daniel J. Lovell, Susan Shenoi, Carlos A. Cuello, Sheila T. Angeles-Han, Mara L. Becker, Randy Q. Cron, Brian M. Feldman, Polly J. Ferguson, Harry Gewanter, Jaime Guzman, Yukiko Kimura, Tzielan Lee, Katherine Murphy, Peter A. Nigrovic, Michael J. Ombrello, C. Egla Rabinovich, Melissa Tesher, Marinka Twilt, Marisa Klein-Gitelman, Fatima Barbar-Smiley, Ashley M. Cooper, Barbara Edelheit, Miriah Gillispie-Taylor, Kimberly Hays, Melissa L. Mannion, Rosemary Peterson, Elaine Flanagan, Nadine Saad, Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James T. Reston

Summary: This study provides recommendations for the management of juvenile idiopathic arthritis, focusing on nonpharmacologic therapies, medication monitoring, immunizations, and imaging. The guideline emphasizes the importance of improving patient quality of life and involving patients and caregivers in decision-making. However, the evidence quality for all recommendations is low.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

Karen B. Onel, Daniel B. Horton, Daniel J. Lovell, Susan Shenoi, Carlos A. Cuello, Sheila T. Angeles-Han, Mara L. Becker, Randy Q. Cron, Brian M. Feldman, Polly J. Ferguson, Harry Gewanter, Jaime Guzman, Yukiko Kimura, Tzielan Lee, Katherine Murphy, Peter A. Nigrovic, Michael J. Ombrello, C. Egla Rabinovich, Melissa Tesher, Marinka Twilt, Marisa Klein-Gitelman, Fatima Barbar-Smiley, Ashley M. Cooper, Barbara Edelheit, Miriah Gillispie-Taylor, Kimberly Hays, Melissa L. Mannion, Rosemary Peterson, Elaine Flanagan, Nadine Saad, Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James T. Reston

Summary: This study provides updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on specific types of JIA and treatment options. The recommendations are based on low-quality evidence and are conditional in nature.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

Karen B. Onel, Daniel B. Horton, Daniel J. Lovell, Susan Shenoi, Carlos A. Cuello, Sheila T. Angeles-Han, Mara L. Becker, Randy Q. Cron, Brian M. Feldman, Polly J. Ferguson, Harry Gewanter, Jaime Guzman, Yukiko Kimura, Tzielan Lee, Katherine Murphy, Peter A. Nigrovic, Michael J. Ombrello, C. Egla Rabinovich, Melissa Tesher, Marinka Twilt, Marisa Klein-Gitelman, Fatima Barbar-Smiley, Ashley M. Cooper, Barbara Edelheit, Miriah Gillispie-Taylor, Kimberly Hays, Melissa L. Mannion, Rosemary Peterson, Elaine Flanagan, Nadine Saad, Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James T. Reston

Summary: This guideline provides recommendations for the management of juvenile idiopathic arthritis, focusing on nonpharmacologic therapies, medication monitoring, immunizations, and imaging. Recommendations include physical therapy and occupational therapy interventions, a healthy diet, medication monitoring, immunizations, and shared decision-making with patients/caregivers.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

Karen B. Onel, Daniel B. Horton, Daniel J. Lovell, Susan Shenoi, Carlos A. Cuello, Sheila T. Angeles-Han, Mara L. Becker, Randy Q. Cron, Brian M. Feldman, Polly J. Ferguson, Harry Gewanter, Jaime Guzman, Yukiko Kimura, Tzielan Lee, Katherine Murphy, Peter A. Nigrovic, Michael J. Ombrello, C. Egla Rabinovich, Melissa Tesher, Marinka Twilt, Marisa Klein-Gitelman, Fatima Barbar-Smiley, Ashley M. Cooper, Barbara Edelheit, Miriah Gillispie-Taylor, Kimberly Hays, Melissa L. Mannion, Rosemary Peterson, Elaine Flanagan, Nadine Saad, Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James T. Reston

Summary: This article provides updated guidelines for the pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on different forms of JIA and providing recommendations for treatment and tapering of medications. The evidence for these recommendations is generally low quality, but the inclusion of patients and caregivers in the decision-making process strengthens the relevance and applicability of the guideline.

ARTHRITIS & RHEUMATOLOGY (2022)

Letter Rheumatology

Relapse and Remission in Children With Chronic Noninfectious Uveitis Treated With Methotrexate

Courtney McCracken, Jessica G. Shantha, Steven Yeh, Kirsten Jenkins, Kelly A. Rouster-Stevens, Scott R. Lambert, Sampath Prahalad, Carolyn Drews-Botsch, Sheila T. Angeles-Han

JOURNAL OF RHEUMATOLOGY (2022)

Editorial Material Rheumatology

Screening, Monitoring, and Treating Children With Juvenile Idiopathic Arthritis-associated Uveitis: Visualizing Better Outcomes

Sheila T. Angeles-Han, Sunil K. Srivastava

JOURNAL OF RHEUMATOLOGY (2023)

Review Immunology

Challenges and management of childhood noninfectious chronic uveitis

Ilaria Maccora, Edoardo Marrani, Ilaria Pagnini, Maria Vincenza Mastrolia, Cinzia de Libero, Roberto Caputo, Gabriele Simonini

Summary: Childhood uveitis is a serious condition that can lead to blindness if not properly recognized and treated. This review discusses the main causes, diagnostic approach, risk factors, and difficulties in eye examination for childhood uveitis. The treatment options for childhood uveitis are also discussed in terms of choice, timing, and withdrawal.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Editorial Material Immunology

Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis

Ilaria Maccora, Preston Land, Virginia Miraldi Utz, Sheila T. Angeles-Han

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Meeting Abstract Ophthalmology

Functional and Psychosocial Impact of Eye Disease in Pediatric Ebola Survivors, Sierra Leone

Dominick Canady, Caleb Hartley, Amy Cassedy, Chris Miller, Sheila T. Angeles-Han, Matthew Jusu Vandy, Gilberte Bastien, Natalie Weil, Steven Yeh, Jessica Shantha

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2021)

Meeting Abstract Ophthalmology

Assessing Visual Function and Quality of Life in Children with JIA and JIA-Uveitis Younger than 7 years Old

Jacob Fondriest, Amy Cassedy, Theresa Hennard, Carolyn Drews-Botsch, Jessi Lipscomb, Courtney McCracken, Joseph McDonald, Sampath Prahalad, Jessica Shantha, Virginia Utz, Steven Yeh, Sheila T. Angeles-Han

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2021)

No Data Available